227 related articles for article (PubMed ID: 20508383)
1. Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study - suggestion for the threshold for impaired fasting glucose among Japanese.
Noda M; Kato M; Takahashi Y; Matsushita Y; Mizoue T; Inoue M; Tsugane S; Kadowaki T
Endocr J; 2010; 57(7):629-37. PubMed ID: 20508383
[TBL] [Abstract][Full Text] [Related]
2. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
[TBL] [Abstract][Full Text] [Related]
3. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
[TBL] [Abstract][Full Text] [Related]
4. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).
Heianza Y; Arase Y; Hsieh SD; Saito K; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
Diabetologia; 2012 Dec; 55(12):3213-23. PubMed ID: 22955996
[TBL] [Abstract][Full Text] [Related]
5. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
[TBL] [Abstract][Full Text] [Related]
7. HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
Nair M; Prabhakaran D; Narayan KM; Sinha R; Lakshmy R; Devasenapathy N; Daniel CR; Gupta R; George PS; Mathew A; Tandon N; Reddy KS
Prim Care Diabetes; 2011 Jul; 5(2):95-102. PubMed ID: 21474403
[TBL] [Abstract][Full Text] [Related]
8. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
[TBL] [Abstract][Full Text] [Related]
9. Should the lower limit of impaired fasting glucose be reduced from 110 mg/dL in Korea?
Ryu S; Shin H; Chang Y; Sung KC; Song J; Lee SJ
Metabolism; 2006 Apr; 55(4):489-93. PubMed ID: 16546479
[TBL] [Abstract][Full Text] [Related]
10. A1C cut points to define various glucose intolerance groups in Asian Indians.
Mohan V; Vijayachandrika V; Gokulakrishnan K; Anjana RM; Ganesan A; Weber MB; Narayan KM
Diabetes Care; 2010 Mar; 33(3):515-9. PubMed ID: 19903752
[TBL] [Abstract][Full Text] [Related]
11. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
Inoue K; Matsumoto M; Akimoto K
Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
[TBL] [Abstract][Full Text] [Related]
12. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG
J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
Gołembiewska E
Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
[TBL] [Abstract][Full Text] [Related]
15. The effect of lowering the threshold for diagnosis of impaired fasting glucose.
Kim SH; Shim WS; Kim EA; Kim EJ; Lee SH; Hong SB; Kim YS; Park SG; Leem JH; Lee HJ; Nam M
Yonsei Med J; 2008 Apr; 49(2):217-23. PubMed ID: 18452257
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans.
McNeely MJ; Boyko EJ; Leonetti DL; Kahn SE; Fujimoto WY
Diabetes Care; 2003 Mar; 26(3):758-63. PubMed ID: 12610034
[TBL] [Abstract][Full Text] [Related]
17. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
Davidson MB; Schriger DL; Peters AL; Lorber B
JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
[TBL] [Abstract][Full Text] [Related]
18. Fasting plasma glucose cutoff for diagnosis of diabetes in a Japanese population.
Doi Y; Kubo M; Yonemoto K; Ninomiya T; Iwase M; Arima H; Hata J; Tanizaki Y; Iida M; Kiyohara Y
J Clin Endocrinol Metab; 2008 Sep; 93(9):3425-9. PubMed ID: 18559920
[TBL] [Abstract][Full Text] [Related]
19. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects.
Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V
J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170
[TBL] [Abstract][Full Text] [Related]
20. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
